OpenAI offered its life sciences model GPT‑Rosalind for free through the Rosalind Biodefense program to support pandemic preparedness and biodefense, named early partners including Lawrence Livermore National Laboratory, Johns Hopkins, and CEPI, and opened applications worldwide.